Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00110773 · ClinicalTrials.gov registry record · Phase 3
S-Caine™ Peel (Skin Numbing Cream) to Treat Pain During Pulsed Dye Laser (PDL) Therapy in Adults
A Phase 3 study, sponsored by ZARS Pharma.
- Completed
- Registry status
- Phase 3
- Development phase
- 80
- Enrollment target
NCT00110773 is a Phase 3 study that has completed, run by ZARS Pharma. The registered enrollment target is 80 participants.
The verdict
NCT00110773, a Phase 3 study, has completed, sponsored by ZARS Pharma.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 80 participants
- Enrollment target
Study Summary
Pulsed dye laser (PDL) on the face is painful. For this reason, local anesthesia is commonly used to eliminate or minimize the pain. S-Caine™ Peel (lidocaine 7% and tetracaine 7% cream) is a eutectic formulation of lidocaine and tetracaine. The purpose of this study is to evaluate the efficacy of S-Caine Peel for induction of local dermal anesthesia for PDL therapy in adults.
Interventions
- DRUG Placebo Peel
- DRUG S-Caine™ Peel (lidocaine and tetracaine topical cream 7%/7%)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2005-06 |
| Est. Completion | 2005-10 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00110773
The ClinicalTrials.gov registry entry for NCT00110773 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 80 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is ZARS Pharma, which has 23 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo Peel is the first listed.
NCT00110773 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00110773 about?
NCT00110773 is a clinical study titled "S-Caine™ Peel (Skin Numbing Cream) to Treat Pain During Pulsed Dye Laser (PDL) Therapy in Adults". Pulsed dye laser (PDL) on the face is painful. For this reason, local anesthesia is commonly used to eliminate or minimize the pain. S-Caine™ Peel (lidocaine 7% and tetracaine 7% cream) is a eutectic formulation of lidocaine and tetracaine. The purpose of this study is to evaluate the efficacy of S-...
What is the current status of trial NCT00110773?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 80 participants. The study started on 2005-06. Estimated completion is 2005-10.
What interventions are being tested in trial NCT00110773?
The interventions under investigation include: Placebo Peel (DRUG), S-Caine™ Peel (lidocaine and tetracaine topical cream 7%/7%) (DRUG).
Who is sponsoring clinical trial NCT00110773?
This trial is sponsored by ZARS Pharma, which has 23 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.